Literature DB >> 31248265

Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review.

Lan Bai1, Xiaofang Li2, Li He2, Yu Zheng1, Haiying Lu1, Jinqi Li1, Lei Zhong1, Rongsheng Tong1, Zhongliang Jiang3, Jianyou Shi1, Jian Li4.   

Abstract

Diabetes mellitus (DM) is a group of metabolic disorders in which high blood sugar levels occur over a prolonged period. Approximately 4% of the global population is affected by DM. Western medical treatment methods for diabetes including injection or oral hypoglycemic drugs have some toxic or side effects, economic pressures, and so on. Many researchers turn to discover new drugs from natural products or Traditional Chinese Medicine (TCM). Flavonoids are widely distributed in plants, and many studies have shown that flavonoids possess antidiabetic properties, exhibiting not only well-recognized antidiabetic and hypoglycemic activities but also activity in the treatment of diabetic complications. In this review, we systematically summarized anti-diabetic flavonoid compounds based on structure classification by examining the PubMed, Springer Link, Web of Science, and CNKI databases. There are 13 flavonoid compounds listed which have been studied extensively and have antidiabetic features respectively. Apigenin, baicalein, and catechin mainly reduces blood glucose via anti-oxidation; hesperidin is good for diabetic neuropathy; glycyrrhiza flavonoids have a significant effect on gestational DM; quercetin takes advantage of crossing the blood-brain barrier and improving renal function. Some compounds have protective and preventive effects on diabetic complications, such as kaempferol and puerarin which are beneficial to cardiomyopathy; myricetin has therapeutic potential in the treatment of DN; dihydromyricetin might improve CI. It is a pity or might be a pointcut that most studies remain in the animal experimental stage, and further investigation should be carried out.

Entities:  

Keywords:  Antidiabetes; Flavonoids; Mechanism; Review; Traditional Chinese Medicine

Mesh:

Substances:

Year:  2019        PMID: 31248265     DOI: 10.1142/S0192415X19500496

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  25 in total

Review 1.  Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Rezaul Islam; Sheikh Shohag; Saikat Mitra; Saad Alghamdi; Ahmad O Babalghith; Abdulrahman Theyab; Mohammad Tauhidur Rahman; Aklima Akter; Abdullah Al Mamun; Fahad A Alhumaydhi; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-21       Impact factor: 2.650

Review 2.  Traditional Chinese medicine promotes bone regeneration in bone tissue engineering.

Authors:  Zheng-Rong Gao; Yun-Zhi Feng; Ya-Qiong Zhao; Jie Zhao; Ying-Hui Zhou; Qin Ye; Yun Chen; Li Tan; Shao-Hui Zhang; Yao Feng; Jing Hu; Ze-Yue Ou-Yang; Marie Aimee Dusenge; Yue Guo
Journal:  Chin Med       Date:  2022-07-20       Impact factor: 4.546

3.  A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease.

Authors:  Xue-Feng Zhou; Wei-E Zhou; Wen-Jing Liu; Min-Jing Luo; Xia-Qing Wu; Ying Wang; Peng Liu; Yu-Min Wen; Jia-Lin Li; Ting-Ting Zhao; Hao-Jun Zhang; Hai-Ling Zhao; Ping Li
Journal:  J Transl Int Med       Date:  2021-06-18

4.  Macrophylloflavone: A New Biflavonoid from Garcinia macrophylla Mart. (Clusiaceae) for Antibacterial, Antioxidant, and Anti-Type 2 Diabetes Mellitus Activities.

Authors:  Hawa Purnama Celala Ary Cane; Nurdin Saidi; Mustanir Yahya; Darusman Darusman; Erlidawati Erlidawati; Safrida Safrida; Musri Musman
Journal:  ScientificWorldJournal       Date:  2020-05-12

Review 5.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16

6.  Joint Transcriptomic and Metabolic Analysis of Flavonoids in Cyclocarya paliurus Leaves.

Authors:  Xiaoling Sheng; Huanwei Chen; Jianmei Wang; Yongli Zheng; Yueling Li; Zexin Jin; Junmin Li
Journal:  ACS Omega       Date:  2021-03-28

Review 7.  Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.

Authors:  Yufan Wu; Zhuxian Wang; Qunqun Du; Zhaoming Zhu; Tingting Chen; Yaqi Xue; Yuan Wang; Quanfu Zeng; Chunyan Shen; Cuiping Jiang; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-17       Impact factor: 2.629

Review 8.  Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity.

Authors:  Ana Maria Udrea; Gratiela Gradisteanu Pircalabioru; Anca Andreea Boboc; Catalina Mares; Andra Dinache; Maria Mernea; Speranta Avram
Journal:  Biomolecules       Date:  2021-11-14

9.  Exploring the Potential Mechanism of Tang-Shen-Ning Decoction against Diabetic Nephropathy Based on the Combination of Network Pharmacology and Experimental Validation.

Authors:  Jiajun Liang; Jiaxin He; Yanbin Gao; Zhiyao Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-09       Impact factor: 2.629

10.  Antidiabetic potential of the isolated fractions from the plants of Rosaceae family in streptozotocin-induced diabetic rats.

Authors:  Gholamreza Bahrami; Babak Izadi; Seyed Shahram Miraghaee; Bahar Mohammadi; Razieh Hatami; Soraya Sajadimajd; Nasim Batooie
Journal:  Res Pharm Sci       Date:  2021-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.